Frisco, TX (PRWEB) September 27, 2011
SomnoMed, Inc., manufacturer of the world's leading oral appliance, SomnoDent for the treatment of Obstructive Sleep Apnea announces that the PDAC Medicare Contractor and each of the four DME MACs have determined that the appropriate HCPCS code to use when billing for the SomnoDent Classic, SomnoDent Flex, and SomnoDent Edentulous is E0486.
According to each of the four DME MAC jurisdictions, in order to be designated code E0486, the oral appliance must be used to reduce upper airway collapsibility, be adjustable, and custom fabricated. A custom-fabricated oral appliance is defined as one that is individually made for a specific patient.
“SomnoMed appreciates the timely decision made by PDAC and the DME MACs and especially those Centers for Medicare & Medicaid Services (CMS) clinicians involved in reviewing SomnoMed’s evidence based application”, said Ralf Barschow, CEO. “SomnoMed would also like to recognize the American Academy of Dental Sleep Medicine (AADSM) and American Academy of Sleep Medicine (AASM) for continuing to develop new standards of practice as well as the American Sleep Apnea Association (ASAA) for their continued dedication to inform and enhance the well-being of those affected by this chronic disease.”
Obstructive Sleep Apnea affects tens of millions of Americans and is associated with obesity, diabetes, high blood pressure, increased risk of heart attack, stroke, memory/performance problems, depression and higher accident rates (J Clin Sleep Med 2009:5(3):263-276). SomnoDent is a medical device used to treat Obstructive Sleep Apnea. Considered a sleeping disorder, this medical condition must be treated with a medical device.
While there are an increasing number of generic oral appliances available, only SomnoDent is independently clinically validated, has a three year warranty and incorporates proprietary materials and design features to maximize patient comfort. SomnoMed firmly believes that dental sleep medicine clinicians will continue to embrace patient-focused and evidence-based medical devices.
SomnoMed is a publically listed dental sleep medicine company (ASX:SOM) providing diagnostic and treatment solutions for Sleep Breathing Disorders such as Obstructive Sleep Apnea. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent is the most comfortable and effective design and treatment solution for over 70,000 patients in 20 countries. For additional information, visit SomnoMed at http://www.somnomed.com.